We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Molecular Diagnostics

Image: New findings shows that specific blood proteins are altered long before multiple sclerosis diagnosis, pointing to a potential approach for pre-symptomatic risk assessment (image credit: Adobe Stock)

Blood Protein Markers Flag Multiple Sclerosis Risk Years Before Diagnosis

Researchers identify plasma proteins altered years before MS, supporting pre-symptomatic risk stratification and prognosis. More...
01 Jun 2026
Image: NHS-Galleri Trial: Percent difference in Stage IV cancers (Photo courtesy of GRAIL)

MCED Blood Test Reduces Stage IV Cancer Diagnoses in NHS Trial

GRAIL reported NHS-Galleri trial findings at ASCO 2026 showing fewer stage IV diagnoses despite missing the combined stage III–IV endpoint. More...
31 May 2026
Image: The updated CRC screening guidance adds a stool RNA test and an updated stool DNA test to the menu of preferred options (image credit: Adobe Stock)

Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests

Guidelines recommend stool RNA and updated stool DNA tests for CRC screening, limiting blood tests due to lower sensitivity. More...
29 May 2026
Image: The new assays target the nucleoprotein (NP) and VP35 regions of the ebolavirus (image credit: 123RF)

Digital PCR Assays Support Surveillance of Bundibugyo Ebolavirus Outbreak

A new dPCR assay set enables rapid, sensitive Bundibugyo ebolavirus detection for research and wastewater surveillance. More...
29 May 2026
Image: The Avantect Pancreatic Cancer Test enables early detection of pancreatic cancer in high-risk patients (Photo courtesy of ClearNote Health)

ClearNote Health to Present Pancreatic Cancer Blood Test Data at ASCO 2026

A new multimodal blood test detects early pancreatic cancer with 76.8% stage I-II sensitivity and 97.5% specificity. More...
28 May 2026
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

A new proteomic blood test helps predict treatment response and progression in NSCLC. More...
28 May 2026
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

New findings highlight the role of MRD detection in breast cancer management, showing that ctDNA monitoring can predict progression up to years earlier. More...
27 May 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Urine Analyzer
respons® UDS100


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.